Maternal and Child Health Practice Questions

Q: Which of the following contraceptive methods has a failure rate of less than 5 in 100 women?

Copper T. The core concept behind this question is the distinction between **"Typical Use"** and **"Perfect Use"** failure rates (Pearl Index) of various contraceptive methods. **1. Why Copper T is Correct:** The Copper T (IUCD) is a **Long-Acting Reversible Contraceptive (LARC)**. Its efficacy is high because it is independent of user compliance. The failure rate for Copper T 380A is approximately **0.8 per 100 women-years** (Typical Use). Since this is significantly less than 5 per 100, it is the correct choice. **2. Analysis of Incorrect Options:** * **Vaginal Sponge:** This is a barrier method with a high failure rate, especially in parous women. Typical use failure rates range from **12% (nulliparous) to 24% (parous)**. * **Diaphragm:** As a user-dependent barrier method requiring consistent and correct placement with spermicide, its typical failure rate is approximately **12 per 100 women-years**. * **Condom:** While effective against STIs, male condoms have a typical use failure rate of about **13–18 per 100 women-years** due to inconsistent use or breakage. **3. NEET-PG High-Yield Pearls:** * **Most Effective:** Implants (0.05%) > Vasectomy (0.1%) > IUCD (0.2–0.8%). * **Tier 1 Contraceptives:** Includes LARCs (IUCDs, Implants) and Permanent Sterilization. All have failure rates ** 12%**. * **Ideal IUCD Candidate:** Monogamous, parous women with no history of PID.

Q: Exclusive breast feeding is recommended by WHO up to what age?

6 months. **Explanation:** **Correct Answer: C. 6 months** The World Health Organization (WHO) and UNICEF recommend **exclusive breastfeeding (EBF)** for the first **6 months (180 days)** of life. Exclusive breastfeeding means the infant receives only breast milk; no other liquids or solids are given—not even water—with the exception of oral rehydration solution (ORS), or drops/syrups of vitamins, minerals, or medicines. **Why 6 months is the standard:** Up to 6 months, breast milk provides all the energy and nutrients an infant needs for healthy growth and development. It offers critical protection against common childhood illnesses like diarrhea and pneumonia. Introducing complementary foods earlier than 6 months is unnecessary and increases the risk of gastrointestinal infections and malnutrition. **Analysis of Incorrect Options:** * **A & B (3-4 months):** Previously, some guidelines suggested introducing solids at 4 months. However, research proved that infants exclusively breastfed for 6 months have fewer infections and no growth deficits compared to those started on solids earlier. * **D (9 months):** By 6 months, an infant's nutritional requirements (especially iron and energy) exceed what breast milk alone can provide. Delaying complementary feeding beyond 6 months can lead to growth faltering and micronutrient deficiencies. **High-Yield Clinical Pearls for NEET-PG:** * **Duration:** Breastfeeding should be initiated within **1 hour** of birth and continued up to **2 years** or beyond along with complementary feeding. * **Colostrum:** The first milk produced (yellowish/thick) is rich in **IgA** and growth factors; it should never be discarded. * **Complementary Feeding:** Should be started at 6 months (181st day). This transition is called **weaning**. * **Indicators:** The "Exclusive Breastfeeding Rate" is a key health indicator, defined as the proportion of infants 0–5 months of age who are fed exclusively with breast milk.

Q: Mala-N is a:

Combined pill. **Explanation:** **Mala-N** is a **Combined Oral Contraceptive Pill (COCP)** provided free of cost by the Government of India under the National Family Planning Programme. 1. **Why it is a Combined Pill:** It contains two hormones: an estrogen and a progestogen. Specifically, each tablet of Mala-N contains **0.03 mg of Ethinyl Estradiol** and **0.15 mg of Levonorgestrel**. The primary mechanism of action is the inhibition of ovulation by suppressing the release of FSH and LH from the pituitary gland. 2. **Why other options are incorrect:** * **POP (Progestogen-Only Pill) / Mini Pill:** These contain only a low dose of progestogen (e.g., Norethisterone or Desogestrel) and no estrogen. They are primarily used during lactation. * **Once a month pill:** These are long-acting hormonal preparations (like Quinestrol) which are not part of the standard Indian national program and have higher failure rates and side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** One pack contains 28 tablets: **21 hormonal pills** and **7 brown iron tablets** (containing 60mg elemental iron as Ferrous Fumarate) to maintain the habit of pill-taking and treat anemia. * **Mala-N vs. Mala-D:** Both have the same hormonal composition. The only difference is that **Mala-N** (N for 'Nishulk') is distributed free at government centers, while **Mala-D** (D for 'Dhan') is a socially marketed brand sold at a subsidized price. * **Centchroman (Saheli):** Do not confuse Mala-N with Saheli. Saheli is a non-steroidal, once-a-week pill containing Ormeloxifene. * **Failure Rate:** The typical failure rate of COCPs is approximately 9% (0.3% with perfect use).

Q: Under the MCH programme, what is the recommended daily dosage of iron and folic acid tablets to be given to mothers?

100 mg iron + 500 mcg folic acid. ### Explanation The correct answer is **A: 100 mg iron + 500 mcg folic acid.** **1. Why Option A is Correct:** Under the **Anemia Mukt Bharat (AMB)** strategy and the National Iron Plus Initiative (NIPI), the prophylactic regimen for pregnant and lactating mothers is one tablet daily containing **100 mg of elemental iron** and **500 mcg (0.5 mg) of folic acid**. This dosage is designed to meet the increased physiological demands of pregnancy, prevent maternal anemia, and reduce the risk of neural tube defects. The regimen starts from the second trimester (after the first 12 weeks) and continues for 180 days during pregnancy and 180 days postpartum. **2. Why Other Options are Incorrect:** * **Option B & C (60 mg iron):** While 60 mg of elemental iron is the WHO recommendation for global prophylaxis, India’s national guidelines (AMB) mandate a higher dose of 100 mg due to the high prevalence of nutritional anemia in the country. * **Option D (100 mcg folic acid):** This dose is insufficient for pregnancy. The standard requirement in the MCH program is 500 mcg to ensure adequate fetal neurodevelopment and maternal health. **3. High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Dose:** If a pregnant woman is diagnosed with clinical anemia (Hb <11 g/dL), the dose is doubled to **two tablets daily** (200 mg iron + 1 mg folic acid). * **IFA for Adolescents (WIFS):** 100 mg iron + 500 mcg folic acid, but given **weekly**, not daily. * **IFA for Children (6–59 months):** 20 mg iron + 100 mcg folic acid (bi-weekly syrup). * **IFA for Children (5–9 years):** 45 mg iron + 400 mcg folic acid (pink tablet, weekly). * **Storage:** IFA tablets are distributed in **Blue** (Adolescents), **Pink** (Children), and **Red** (Pregnant/Lactating) packaging to ensure compliance.

Q: All of the following are true about Janani Shishu Suraksha Karyakram (JSSK) except:

Free treatment of children up to 18 years of age. **Explanation:** The **Janani Shishu Suraksha Karyakram (JSSK)**, launched on June 1, 2011, is a national initiative aimed at eliminating out-of-pocket expenses for pregnant women and sick newborns. **Why Option D is the correct answer:** JSSK provides free treatment for **sick infants (up to 1 year of age)**, not children up to 18 years. The age limit was initially 30 days (neonates) but was later extended to cover all infants up to one year. Treatment for children up to 18 years for specific health conditions (4 Ds: Defects, Deficiencies, Diseases, Developmental delays) is covered under the **Rashtriya Bal Swasthya Karyakram (RBSK)**, not JSSK. **Analysis of Incorrect Options:** * **Option A:** JSSK entitles pregnant women to a **free diet** during their stay in the health facility (up to 3 days for normal delivery and 7 days for C-section). * **Option B:** It guarantees **free and cashless delivery**, including both normal vaginal deliveries and Caesarean sections, in public health institutions. * **Option C:** It provides **free transport** from home to the facility, between facilities in case of referral, and back home after discharge. **High-Yield Clinical Pearls for NEET-PG:** * **Target Group:** All pregnant women (including complications) and sick infants (up to 1 year). * **Key Entitlements:** Free drugs, consumables, diagnostics (blood/urine tests, USG), blood provision, and exemption from all user charges. * **JSSK vs. JSY:** While **JSY (Janani Suraksha Yojana)** is a conditional cash transfer scheme to promote institutional delivery, **JSSK** is an entitlement scheme to ensure zero-cost care. * **Extension:** JSSK entitlements have also been extended to all antenatal and postnatal complications.

Q: What is the National Rural Health Mission (NRHM) goal for Infant Mortality Rate (IMR) reduction?

30%. ### Explanation **1. Why the Correct Answer is Right:** The National Rural Health Mission (NRHM), launched in 2005, established specific, time-bound targets to improve maternal and child health indicators in India. The primary goal for the **Infant Mortality Rate (IMR)** was to reduce it to **30 per 1,000 live births** (often simplified in exam questions as a target of "30"). This target was set to ensure a significant decline from the baseline levels of the early 2000s through interventions like Janani Suraksha Yojana (JSY) and improved immunization coverage. **2. Analysis of Incorrect Options:** * **Option A (10%):** This is too high for a national health goal. While 10 is the target for some specific disease elimination programs (like reducing Malaria incidence), it was never the NRHM target for IMR. * **Option C (40%):** While the IMR was around 40-50 during the mid-phases of NRHM, the *goal* was always more ambitious (30). A target of 40 would have represented insufficient progress. * **Option D (None of the above):** Incorrect, as 30 is the officially documented goal in the NRHM framework. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **NRHM Launch:** 12th April 2005 (merged into National Health Mission/NHM in 2013). * **Maternal Mortality Ratio (MMR) Goal:** Reduce to **100 per 100,000 live births**. * **Total Fertility Rate (TFR) Goal:** Reduce to **2.1** (Replacement level fertility). * **Current Status:** As per the latest SRS (Sample Registration System) data, India’s IMR has seen a significant decline, though it varies across states. * **IMR Components:** Remember that **Neonatal Mortality Rate (NMR)** contributes to nearly 70-75% of the IMR in India; hence, NRHM focuses heavily on facility-based newborn care.

Q: Which contraceptive intrauterine device (IUD) is associated with the highest pregnancy rate?

Lippes loop IUD. **Explanation:** The efficacy of an Intrauterine Device (IUD) is primarily determined by its generation and the presence of bioactive substances (copper or hormones). **1. Why Lippes Loop is the correct answer:** The **Lippes Loop** is a **first-generation, non-medicated (inert)** IUD made of polyethylene. Because it lacks bioactive components like copper or progestogens, its contraceptive action relies solely on a local foreign body inflammatory response in the endometrium. This mechanism is less effective than newer models, resulting in a higher failure rate (Pregnancy rate: **~3 per 100 woman-years**). **2. Analysis of Incorrect Options:** * **Copper T IUD (Second Generation):** These medicated IUDs release copper ions which are toxic to sperm (spermicidal) and inhibit fertilization. They have significantly lower failure rates (e.g., CuT 380A has a pregnancy rate of **<1 per 100 woman-years**). * **Progestasert (Third Generation):** This is a hormone-releasing IUD that releases progesterone. While it has a lower failure rate than the Lippes Loop (~1.3–2.0%), it is less effective than the LNG-IUD and requires yearly replacement. * **LNG-IUD (Mirena):** This is the most effective reversible contraceptive method. It thickens cervical mucus and suppresses the endometrium, with a failure rate of approximately **0.2 per 100 woman-years**, comparable to tubal sterilization. **Clinical Pearls for NEET-PG:** * **Highest Failure Rate:** Lippes Loop (Inert IUD). * **Lowest Failure Rate:** LNG-IUD (Mirena). * **Most Common Side Effect of IUDs:** Bleeding (especially with Copper IUDs). * **Most Common Reason for Removal:** Bleeding and Pain. * **Ideal Candidate for IUD:** A multiparous woman in a stable monogamous relationship.

Q: What is the difference between the Mala-N and Mala-D oral contraceptive pills?

Provision free of cost. **Explanation:** The distinction between **Mala-N** and **Mala-D** lies solely in their **distribution channel and cost**, not their pharmacological composition. Both are Combined Oral Contraceptive Pills (COCPs) containing the same hormonal formulation: **Levonorgestrel (0.15 mg)** and **Ethinyl Estradiol (0.03 mg)**, along with 7 ferrous fumarate tablets. 1. **Why Option D is Correct:** * **Mala-N (N for 'National'):** Distributed **free of cost** through the government healthcare delivery system (PHCs, CHCs, and Sub-centers) under the National Family Welfare Programme. * **Mala-D (D for 'Demand'):** Distributed under the **Social Marketing Scheme**. It is sold at a highly subsidized nominal rate (currently approx. ₹3-5 per cycle) through private retailers and chemists to increase accessibility for those who prefer buying from shops. 2. **Why Other Options are Incorrect:** * **Options A & B:** Both pills are identical in their hormonal content. There is no difference in the dosage of Progestogen (Levonorgestrel) or Estrogen (Ethinyl Estradiol). * **Option C:** This describes Mala-D, not the difference between the two. While Mala-D is sold under social marketing, Mala-N is not. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** 0.15 mg Levonorgestrel + 0.03 mg Ethinyl Estradiol (Low-dose pill). * **Schedule:** 21 hormonal pills + 7 iron pills (to maintain the habit and treat anemia). * **Mechanism:** Primarily prevents ovulation by suppressing LH and FSH. * **Centchroman (Chhaya):** A non-steroidal, non-hormonal "Once-a-week" pill also provided free under the National Programme. * **Antara:** The injectable contraceptive (DMPA) provided under the same program.

Question 1

Which of the following contraceptive methods has a failure rate of less than 5 in 100 women?

Accepted Answer

Copper T

Answer

Vaginal sponge

Answer

Diaphragm

Answer

Condom

Question 2

Exclusive breast feeding is recommended by WHO up to what age?

Accepted Answer

6 months

Answer

3 months

Answer

4 months

Answer

9 months

Question 3

Mala-N is a:

Accepted Answer

Combined pill

Answer

POP pill

Answer

Mini pill

Answer

Once a month pill

Question 4

Which component of ART is given to the mother for the prevention of mother-to-child transmission?

Accepted Answer

Tenofovir, Efavirenz, and Lamivudine

Answer

Lamivudine and Efavirenz

Answer

Nevirapine and Lamivudine

Answer

Tenofovir, Efavirenz, and Stavudine

Question 5

Under the MCH programme, what is the recommended daily dosage of iron and folic acid tablets to be given to mothers?

Accepted Answer

100 mg iron + 500 mcg folic acid

Answer

60 mg iron + 500 mcg folic acid

Answer

60 mg iron + 100 mcg folic acid

Answer

100 mg iron + 100 mcg folic acid

Question 6

All of the following are true about Janani Shishu Suraksha Karyakram (JSSK) except:

Accepted Answer

Free treatment of children up to 18 years of age

Answer

Free diet to mother during hospital stay

Answer

Free delivery

Answer

Free transport from home to hospital and back

Question 7

What is the National Rural Health Mission (NRHM) goal for Infant Mortality Rate (IMR) reduction?

Accepted Answer

30%

Answer

10%

Answer

40%

Answer

None of the above

Question 8

Which contraceptive intrauterine device (IUD) is associated with the highest pregnancy rate?

Accepted Answer

Lippes loop IUD

Answer

Copper T IUD

Answer

Progestasert IUD

Answer

Levonorgestrel-releasing IUD (LNG-IUD)

Question 9

What is the difference between the Mala-N and Mala-D oral contraceptive pills?

Accepted Answer

Provision free of cost

Answer

Norgestrol dosage

Answer

Estradiol dosage

Answer

Sale under a social marketing scheme

Question 10

In young infants, pneumonia is classified by which of the following signs?

Accepted Answer

Fast breathing

Answer

Wheezing

Answer

Fever

Answer

Chest indrawing

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?